Twist Bioscience officer plans 949-share sale
The notice also lists seven earlier common-stock sales by Dennis H. Cho, dated August 3 through October 2, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Twist Bioscience Corp (TWST) officer Dennis H. Cho reported a planned sale of 949 common shares, with an aggregate market value of $128,496.21 and an approximate sale date of November 3, 2026, through Fidelity Brokerage Services LLC. The notice identifies the shares as restricted stock vesting from the issuer on November 2, 2026, and says the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.